Company Profile

INSILCO LTD.

NSE : NABSE : 500211ISIN CODE : INE901A01011Industry : Chemicals House : Insilco - MNC
BSE6.81-0.15 (-2.16 % )
PREV CLOSE (Rs.) 6.96
OPEN PRICE (Rs.) 7.00
BID PRICE (QTY) 0.00 (0 )
OFFER PRICE (QTY) 0.00 (0 )
VOLUME 40976
TODAY'S LOW / HIGH (Rs.)6.75 7.15
52 WK LOW / HIGH (Rs.) 5.73 12
NSE
This Company is not listed in NSE

Smart Quotes

1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Trade Value (Rs. in Lacs) 2.80543
Dividend Yield(%)
TTM EPS (Rs.)
P/E Ratio
Book Value (Rs.)
Face Value (Rs.)
MCap (Rs. in Mn)
Price/Earning (TTM)
Price/Sales (TTM)
Price/Book (MRQ)
PAT Margin (%) -18.14
ROCE (%) -11.46
Incorporation Year : 1988

Management Info :

Dara Phirozeshaw Mehta - Chairman Brijesh Arora - Managing Director

Registered Office :

Address : A 5,U P S I D C Industrial Estate,Bhartiagram,
Gajraula,
Uttar Pradesh-244223

Phone : (0) 98378 23893, 98379 23893

Registrar's Details : MCS Ltd
F-65, ,Okhla Industrial Area,Phase - I,New Delhi
Listing : BSE, NSE
NEWS More
03May05-03-2021$Appointment of Director Appointment of Director
inter alia, approved the Appointment of Mr. Vinod Paremal (DIN:08803466) as Managing Director of the Company.
inter alia, approved the Appointment of Mr. Vinod Paremal (DIN:..
30Mar03-30-2021$ Outcome Of Board Meeting Dated 30.03.2021 - Way Forward Outcome Of Board Meeting Da
Pursuant to the provisions of Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 and further to our letter dated February 10, 2021, this is to inform you that the Board of the Company reviewed various options of the way forward for the Company. The Board is of the opinion that there is no availability of business prospects nor any long-term financial resources that presents a financially viable alternative to carry on the business activities of the Company or to resume the operations of the Company in the foreseeable future. The Board granted its in-principle approval for the voluntary liquidation of the Company. This decision is subject to the final approval of Board of the Company.
Pursuant to the provisions of Regulation 30 of the Securities a..
25Mar03-25-2021$ Outcome Of Board Meeting - Termination Of Agreements With Related Parties Outcome Of Board Meeting -
Pursuant to the provisions of the Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that the Board of the Company at its meeting held today has approved the termination of the following agreements: 1. Related party termination agreement with Evonik India Private Limited (Marketing and Sales Promotion Agreement) 2. Related party termination agreement with Evonik IP GmbH (Assignment Agreement) 3. Related party termination agreement with Evonik Iran AG (Agency Agreement) The same is for your information.
Pursuant to the provisions of the Regulation 30 of the Securiti..
11Dec12-11-2020$Insilco informs about change in directorate Insilco informs about change

In terms of Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with Circular No. CIR/CFD/CMD/4/2015 dated September 9, 2015 issued by the Securities and Exchange Board of India, Insilco  has informed about disclosure with regard to change in directorate of the Company as follows: Appointment of Gopalakrishnan Anantharaman Iyer (DIN: 00388092) as an Additional Director of the Company, Resignation of Brijesh Arora (DIN: 00952523) as Managing Director.

The above information is a part of company’s filings submitted to BSE.

In terms of Regulation 30 of the Securities and Exchange Board..
10Dec12-10-2020$Insilco informs about outcome of board meeting Insilco informs about outcom

Insilco has informed about outcome of board meeting.

The above information is a part of company’s filings submitted to BSE.

Insilco has informed about outcome of board meeting. The above..
Financials More
Rs. in Millions
QTR Dec 20 ANNUAL 20
Net Profit-314.9-104.7
Gross Profit -319.1 -102.7
Operating Profit -307.1-74.3
Net Sales 577.5
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group More
Kanchi Karpooram (BSE)
 1109.90 (5.11%)
M.Cap ( in Cr)
479.36
Indian Toners & Dev (BSE)
 183.95 (19.99%)
M.Cap ( in Cr)
199.59
Rossari Biotech (BSE)
 1287.70 (2.43%)
M.Cap ( in Cr)
7074.81
Valiant Organics (BSE)
 1782.05 (1.20%)
M.Cap ( in Cr)
4838.89
Ultramar & Pigments (BSE)
 427.70 (5.15%)
M.Cap ( in Cr)
1248.88
Shareholding Pattern More
PROMOTERS 73.11 %
NON-INSTITUTION 26.83 %
FI/BANKS/INSURANCE 0.04 %
MUTUAL FUNDS/UTI 0.02 %
GOVERNMENT 0 %
FII 0 %
MF HOLDINGS
Scheme NameHold(%)
No Data Found
F & O Quotes